Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

NCT04606563 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

341

Enrollment

OTHER

Sponsor class

Stopped DSMC recommendation due to futility

Conditions

Covid19
SARS-CoV Infection

Interventions

DRUG: Losartan
DRUG: Valsartan
DRUG: Azilsartan
DRUG: Candesartan
DRUG: Eprosartan
DRUG: Irbesartan
DRUG: Olmesartan
DRUG: Telmisartan

Sponsor

University of British Columbia

Collaborators

[object Object]